Cargando…
A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis
Secondary hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease. In the present retrospective study, we aimed to investigate coagulation disorders and their outcome implications in patients with secondary HLH. We evaluated clinical characteristics and the relationship between coagul...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567857/ https://www.ncbi.nlm.nih.gov/pubmed/37561154 http://dx.doi.org/10.1007/s00277-023-05398-w |
_version_ | 1785119228892807168 |
---|---|
author | Wang, Shixuan Lv, Kebing Zhou, Yulan Cheng, Xiaoye Chen, Zhiwei Shen, Huimin Li, Fei |
author_facet | Wang, Shixuan Lv, Kebing Zhou, Yulan Cheng, Xiaoye Chen, Zhiwei Shen, Huimin Li, Fei |
author_sort | Wang, Shixuan |
collection | PubMed |
description | Secondary hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease. In the present retrospective study, we aimed to investigate coagulation disorders and their outcome implications in patients with secondary HLH. We evaluated clinical characteristics and the relationship between coagulation indices and prognosis in HLH patients (n = 141). The information, including clinical symptoms, laboratory indicators, and coagulation indices, was evaluated. Coagulation disorders and bleeding events occurred in 95 (67.4%) and 60 (42.6%) patients, respectively. A coagulation index analysis primarily showed elevated levels of D-Dimer, the international standardized ratio (INR), prothrombin time (PT), activated partial thromboplastin time (APTT), and thrombin time (TT), while the prothrombin activity, fibrinogen levels, and platelet levels were significantly decreased. Dominant disseminated intravascular coagulation (DIC) occurred in 76 patients (53.9%). Patients with lymphoma-associated hemophagocytic syndrome (LAHS) frequently exhibited apparent coagulation disorders. Multivariate analysis revealed that age ≥ 29.5 years, bleeding events, APTT ≥ 47.3 s, fibrinogen ≤ 1.68 g/L, and absolute neutrophil counts (ANC) of ≤ 1.21 × 10(9)/L were independent prognostic factors. We thereby devised a prognostic scoring system and stratified patients into low-risk (0–2 points), intermediate-risk (3–4 points), and high-risk (5–7 points) groups, and the 1-year overall survival rates in the above-mentioned groups were 66.40%, 40.00%, and 2.30%, respectively (P < 0.0001). In conclusion, coagulation dysfunctions and bleeding tendencies were common characteristics in HLH patients. We constructed a novel prognostic score model based on APTT, fibrinogen level, ANC, age, and bleeding events, which had superior prognostic value compared with these markers alone. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00277-023-05398-w. |
format | Online Article Text |
id | pubmed-10567857 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-105678572023-10-13 A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis Wang, Shixuan Lv, Kebing Zhou, Yulan Cheng, Xiaoye Chen, Zhiwei Shen, Huimin Li, Fei Ann Hematol Original Article Secondary hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease. In the present retrospective study, we aimed to investigate coagulation disorders and their outcome implications in patients with secondary HLH. We evaluated clinical characteristics and the relationship between coagulation indices and prognosis in HLH patients (n = 141). The information, including clinical symptoms, laboratory indicators, and coagulation indices, was evaluated. Coagulation disorders and bleeding events occurred in 95 (67.4%) and 60 (42.6%) patients, respectively. A coagulation index analysis primarily showed elevated levels of D-Dimer, the international standardized ratio (INR), prothrombin time (PT), activated partial thromboplastin time (APTT), and thrombin time (TT), while the prothrombin activity, fibrinogen levels, and platelet levels were significantly decreased. Dominant disseminated intravascular coagulation (DIC) occurred in 76 patients (53.9%). Patients with lymphoma-associated hemophagocytic syndrome (LAHS) frequently exhibited apparent coagulation disorders. Multivariate analysis revealed that age ≥ 29.5 years, bleeding events, APTT ≥ 47.3 s, fibrinogen ≤ 1.68 g/L, and absolute neutrophil counts (ANC) of ≤ 1.21 × 10(9)/L were independent prognostic factors. We thereby devised a prognostic scoring system and stratified patients into low-risk (0–2 points), intermediate-risk (3–4 points), and high-risk (5–7 points) groups, and the 1-year overall survival rates in the above-mentioned groups were 66.40%, 40.00%, and 2.30%, respectively (P < 0.0001). In conclusion, coagulation dysfunctions and bleeding tendencies were common characteristics in HLH patients. We constructed a novel prognostic score model based on APTT, fibrinogen level, ANC, age, and bleeding events, which had superior prognostic value compared with these markers alone. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00277-023-05398-w. Springer Berlin Heidelberg 2023-08-10 2023 /pmc/articles/PMC10567857/ /pubmed/37561154 http://dx.doi.org/10.1007/s00277-023-05398-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Wang, Shixuan Lv, Kebing Zhou, Yulan Cheng, Xiaoye Chen, Zhiwei Shen, Huimin Li, Fei A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis |
title | A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis |
title_full | A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis |
title_fullStr | A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis |
title_full_unstemmed | A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis |
title_short | A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis |
title_sort | novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567857/ https://www.ncbi.nlm.nih.gov/pubmed/37561154 http://dx.doi.org/10.1007/s00277-023-05398-w |
work_keys_str_mv | AT wangshixuan anovelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis AT lvkebing anovelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis AT zhouyulan anovelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis AT chengxiaoye anovelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis AT chenzhiwei anovelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis AT shenhuimin anovelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis AT lifei anovelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis AT wangshixuan novelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis AT lvkebing novelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis AT zhouyulan novelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis AT chengxiaoye novelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis AT chenzhiwei novelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis AT shenhuimin novelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis AT lifei novelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis |